Eubel Brady & Suttman Asset Management Inc. Has $22.37 Million Stock Position in Kenvue Inc. $KVUE

Eubel Brady & Suttman Asset Management Inc. lowered its stake in shares of Kenvue Inc. (NYSE:KVUE) by 5.5% during the 4th quarter, Holdings Channel.com reports. The firm owned 1,297,059 shares of the company’s stock after selling 74,827 shares during the quarter. Kenvue accounts for approximately 2.5% of Eubel Brady & Suttman Asset Management Inc.’s portfolio, making the stock its 15th biggest position. Eubel Brady & Suttman Asset Management Inc.’s holdings in Kenvue were worth $22,374,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in KVUE. Arrowstreet Capital Limited Partnership acquired a new position in shares of Kenvue during the second quarter valued at about $6,528,000. Jump Financial LLC raised its holdings in shares of Kenvue by 210.6% during the second quarter. Jump Financial LLC now owns 54,823 shares of the company’s stock valued at $1,147,000 after purchasing an additional 37,170 shares during the period. AXA S.A. raised its holdings in shares of Kenvue by 21.1% during the second quarter. AXA S.A. now owns 48,892 shares of the company’s stock valued at $1,023,000 after purchasing an additional 8,524 shares during the period. NewEdge Advisors LLC raised its holdings in shares of Kenvue by 219.1% during the second quarter. NewEdge Advisors LLC now owns 97,481 shares of the company’s stock valued at $2,040,000 after purchasing an additional 66,930 shares during the period. Finally, The Manufacturers Life Insurance Company raised its holdings in shares of Kenvue by 0.6% during the second quarter. The Manufacturers Life Insurance Company now owns 1,873,705 shares of the company’s stock valued at $39,217,000 after purchasing an additional 10,885 shares during the period. Institutional investors and hedge funds own 97.64% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on KVUE. Argus upgraded shares of Kenvue to a “hold” rating in a report on Friday, March 6th. Canaccord Genuity Group upped their target price on shares of Kenvue from $17.00 to $18.00 and gave the stock a “hold” rating in a report on Wednesday, February 18th. Barclays lowered their target price on shares of Kenvue from $19.00 to $18.00 and set an “equal weight” rating on the stock in a report on Tuesday, April 14th. Weiss Ratings upgraded shares of Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, May 8th. Finally, Citigroup lowered their target price on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating on the stock in a report on Wednesday, April 15th. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and twelve have given a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $19.33.

Insider Buying and Selling at Kenvue

In other news, General Counsel Matthew Orlando sold 38,491 shares of the stock in a transaction that occurred on Friday, May 8th. The shares were sold at an average price of $17.66, for a total transaction of $679,751.06. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 1.59% of the stock is owned by corporate insiders.

Kenvue Stock Down 0.6%

Kenvue stock opened at $17.09 on Friday. Kenvue Inc. has a twelve month low of $14.02 and a twelve month high of $24.35. The firm has a 50 day moving average price of $17.48 and a 200-day moving average price of $17.32. The company has a market capitalization of $32.81 billion, a P/E ratio of 20.10, a P/E/G ratio of 1.30 and a beta of 0.55. The company has a quick ratio of 0.68, a current ratio of 0.98 and a debt-to-equity ratio of 0.67.

Kenvue (NYSE:KVUE) last released its earnings results on Thursday, May 7th. The company reported $0.32 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.05. Kenvue had a net margin of 10.61% and a return on equity of 20.81%. The firm had revenue of $3.91 billion during the quarter, compared to the consensus estimate of $3.84 billion. During the same period in the prior year, the firm earned $0.24 EPS. The company’s revenue was up 4.5% compared to the same quarter last year. As a group, equities analysts predict that Kenvue Inc. will post 1.16 EPS for the current year.

Kenvue Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 27th. Stockholders of record on Wednesday, May 13th will be given a dividend of $0.2075 per share. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.9%. The ex-dividend date of this dividend is Wednesday, May 13th. Kenvue’s dividend payout ratio is currently 97.65%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.